ARCHIVES

Reinventing NCI: Clinical Trials System Changes Not Easy Or Quick, Klausner Says; NCAB Members, Others, Sound Off On Group’s Report

This article is from The Cancer Letter archive.

Vol. 23 No. 39 | October 10, 1997

Download PDF Visit The Full Archive

Related Articles

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

Consortium Centers Pose Problems To Some, But claim They “Coincide With Congress’ Intent”

December 9, 1977

Hammer Gives $100,000 to Expand Rosenberg’s T-Cell Growth Factor Clinical Studies

March 1, 1985

House Members Form Group To Address Cancer Policy.

February 23, 2001

FDA Grants Orphan Designation To E7777 in T-Cell Lymphoma

August 30, 2013

NIH Guidelines Define Eligible Research Using Stem Cells.

September 8, 2000